Skip to main content
Photocure ASA logo

Photocure ASA — Investor Relations & Filings

Ticker · PHO ISIN · NO0010000045 LEI · 5967007LIEEXZXG8OW35 OL Manufacturing
Filings indexed 1,331 across all filing types
Latest filing 2014-05-27 AGM Information
Country NO Norway
Listing OL PHO

About Photocure ASA

https://www.photocure.com/

Photocure is a specialty pharmaceutical company focused on bladder cancer. It develops and commercializes products and medical devices based on proprietary photodynamic technology. The company's primary offering is Blue Light Cystoscopy (BLC) with its imaging agents, Hexvix®/Cysview®, which is used for the improved detection and management of bladder cancer. Photocure aims to deliver transformative solutions to the urologic oncology community to improve patient outcomes. The company is also engaged in developing advanced diagnostic technologies, including the integration of artificial intelligence with its BLC systems.

Recent filings

Filing Released Lang Actions
Photocure ASA: Minutes from Annual General Meeting
AGM Information Classification · 99% confidence The document is explicitly titled "Photocure ASA: Minutes from Annual General Meeting" and confirms that the Annual General Meeting (AGM) took place on May 27, 2014. It details the election of a new Board of Directors. Although it mentions 'Minutes from the meeting' are attached, the core content provided is the summary/result of the AGM itself, specifically regarding board elections, which aligns closely with AGM-related materials. Given the options, AGM-R (AGM Information) is the most appropriate classification for minutes and key outcomes of an Annual General Meeting.
2014-05-27 English
Photocure ASA: Share Option Program
Remuneration Information Classification · 99% confidence The document is a 'Stock Exchange Notice' announcing the award of share options to the management team under the company's share option program. This directly relates to the compensation and holdings of directors/executives. This aligns best with the 'Director's Dealing' (DIRS) category, which covers reports of personal share transactions by directors and executives, or potentially 'Remuneration Information' (DEF 14A). However, DIRS specifically covers transactions/holdings changes for insiders, which share option awards are a form of. Since it details specific option grants and resulting holdings for the CEO and other executives, DIRS is the most precise fit over the broader DEF 14A (which usually covers full compensation packages). It is not a general financing announcement (CAP) or a general regulatory filing (RNS).
2014-05-14 English
Photocure ASA: Share Option Program
Remuneration Information Classification · 99% confidence The document is extremely short (252 characters) and announces a 'Share Option Program' under Norwegian Securities Trading Act disclosure requirements. It does not contain the substance of a financial report, management change, or dividend notice. Since 'Share Option Program' is not explicitly covered by the specific codes (like CAP for financing or DIRS for insider trades), and given its nature as a brief regulatory disclosure announcement, it best fits the general regulatory announcement category, which is RNS (Regulatory Filings), or potentially CAP if the options are considered a capital structure change. However, RNS is the designated fallback for miscellaneous regulatory announcements that don't fit elsewhere. Given the brevity and announcement nature, RNS is the most appropriate general classification.
2014-05-14 English
Photocure ASA: Results for the first quarter 2014
Investor Presentation Classification · 100% confidence The document is a presentation titled 'RESULTS OF THE FIRST QUARTER 2014' for Photocure ASA. It contains detailed financial highlights, pipeline updates, profit and loss statements, cash flow analysis, and balance sheet data for the first quarter of 2014. As it is a detailed presentation for investors focusing on financials, strategy, and market position, it fits the definition of an Investor Presentation. Q1 2014
2014-05-07 Norwegian
Photocure ASA: Results for the first quarter 2014
Earnings Release Classification · 99% confidence The document explicitly states, "Results for first quarter 2014" and provides detailed financial tables, key figures, an operating review, and a financial review for the first quarter (1Q 2014). The text also mentions, "The financial report as of 31 March 2014 has been prepared in accordance with IAS 34 Interim Financial Reporting." IAS 34 governs Interim Financial Reporting, which corresponds to quarterly or semi-annual reports, not the full annual report (10-K). Since this is a comprehensive report covering a period shorter than a year (Q1), it fits the definition of an Interim / Quarterly Report (IR). It is not merely an Earnings Release (ER) as it contains extensive operational and financial details, nor is it a Report Publication Announcement (RPA) because the full content is present, not just a notice of publication. Q1 2014
2014-05-07 Norwegian
Photocure ASA: Results for the first quarter 2014
Earnings Release Classification · 100% confidence The document explicitly states it contains the "Results for the first quarter 2014" for Photocure ASA. It provides key financial highlights, a detailed table of key figures comparing Q1 2014 to Q1 2013, CEO commentary, and details about an upcoming presentation/conference call. This structure is characteristic of an Earnings Release (ER) or an Interim/Quarterly Report (IR). Since it contains detailed financial tables and commentary, it goes beyond just the initial highlights typical of a pure ER, leaning towards a comprehensive quarterly report. However, the document itself is an announcement/press release summarizing the results, not the full, detailed statutory report (which would likely be filed as a 10-Q equivalent or a more formal IR document). Given the content focuses on summarizing the period's performance and announcing the presentation, 'Earnings Release' (ER) is the most appropriate classification for this type of press release summarizing quarterly results. Q1 2014
2014-05-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.